These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37435061)

  • 21. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
    Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
    [No Abstract]   [Full Text] [Related]  

  • 22. AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.
    Höpker K; Hagmann H; Khurshid S; Chen S; Hasskamp P; Seeger-Nukpezah T; Schilberg K; Heukamp L; Lamkemeyer T; Sos ML; Thomas RK; Lowery D; Roels F; Fischer M; Liebau MC; Resch U; Kisner T; Röther F; Bartram MP; Müller RU; Fabretti F; Kurschat P; Schumacher B; Gaestel M; Medema RH; Yaffe MB; Schermer B; Reinhardt HC; Benzing T
    EMBO J; 2012 Oct; 31(20):3961-75. PubMed ID: 22909821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
    Du Y; Liu X; Guo SW
    Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
    Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
    Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
    Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses.
    Della Chiesa M; Romagnani C; Thiel A; Moretta L; Moretta A
    Blood; 2006 Dec; 108(12):3851-8. PubMed ID: 16873676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention.
    Molfetta R; Zingoni A; Santoni A; Paolini R
    Front Immunol; 2019; 10():2557. PubMed ID: 31736972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovering Che-1/AATF: a new attractive target for cancer therapy.
    Iezzi S; Fanciulli M
    Front Genet; 2015; 6():141. PubMed ID: 25914721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cancer activity and mechanistic features of a NK cell activating molecule.
    Kim HR; Lee KH; Park SJ; Kim SY; Yang YK; Tae J; Kim J
    Cancer Immunol Immunother; 2009 Oct; 58(10):1691-700. PubMed ID: 19259669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
    Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
    Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter.
    Di Padova M; Bruno T; De Nicola F; Iezzi S; D'Angelo C; Gallo R; Nicosia D; Corbi N; Biroccio A; Floridi A; Passananti C; Fanciulli M
    J Biol Chem; 2003 Sep; 278(38):36496-504. PubMed ID: 12847090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].
    Catros V; Dessarthe B; Thedrez A; Toutirais O
    Med Sci (Paris); 2014 May; 30(5):537-43. PubMed ID: 24939541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
    Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A
    Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms.
    Bilotta MT; Abruzzese MP; Molfetta R; Scarno G; Fionda C; Zingoni A; Soriani A; Garofalo T; Petrucci MT; Ricciardi MR; Paolini R; Santoni A; Cippitelli M
    FASEB J; 2019 Aug; 33(8):9489-9504. PubMed ID: 31125275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Che-1/AATF binds to RNA polymerase I machinery and sustains ribosomal RNA gene transcription.
    Sorino C; Catena V; Bruno T; De Nicola F; Scalera S; Bossi G; Fabretti F; Mano M; De Smaele E; Fanciulli M; Iezzi S
    Nucleic Acids Res; 2020 Jun; 48(11):5891-5906. PubMed ID: 32421830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells
    Focaccetti C; Benvenuto M; Pighi C; Vitelli A; Napolitano F; Cotugno N; Fruci D; Palma P; Rossi P; Bei R; Cifaldi L
    Front Immunol; 2022; 13():886319. PubMed ID: 35967339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.